Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1989:37 Suppl 1:32-6; discussion 69-77.
doi: 10.2165/00003495-198900371-00008.

Nedocromil sodium inhibition of IgE-mediated activation of human mononuclear phagocytes and platelets from asthmatics

Affiliations

Nedocromil sodium inhibition of IgE-mediated activation of human mononuclear phagocytes and platelets from asthmatics

M Joseph et al. Drugs. 1989.

Abstract

The demonstration of a specific receptor for IgE on non-mast cell or basophil leucocytes, such as mononuclear phagocytes, eosinophils and platelets, suggests that these cells may participate directly in immunological disorders of allergy. In this study, inhibition by nedocromil sodium of IgE-dependent activation of human alveolar macrophages, blood monocytes and platelets was investigated. Nedocromil sodium produced an inhibition of IgE-mediated generation of cytotoxic molecules from monocytes and platelets together with a concomitant inhibition of their oxidative metabolism, measured by chemiluminescence. In addition, nedocromil sodium reduced the ability of alveolar macrophages to synthesise and release mediators, estimated by beta-glucuronidase activity. Furthermore, nedocromil sodium inhibited the abnormal response to aspirin of platelets from aspirin-sensitive asthmatics at therapeutic concentrations. These studies confirm that nedocromil sodium acts on a cell compartment other than the classical mast cell population in IgE-dependent allergy and asthma.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Thorax. 1981 Nov;36(11):866-9 - PubMed
    1. Eur J Clin Invest. 1980 Dec;10(6):437-41 - PubMed
    1. Int Arch Allergy Appl Immunol. 1988;85(2):227-31 - PubMed
    1. Int Arch Allergy Appl Immunol. 1988;85(2):232-7 - PubMed
    1. J Allergy Clin Immunol. 1984 Dec;74(6):827-34 - PubMed

MeSH terms